Aspirin

Product NDC: 41163-945
11-digit product format: 411630945
Labeler code: 41163
Product ID: 41163-945_0be86198-787e-4198-8ff8-3e4107e421c4
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: United Natural Foods, Inc. dba UNFI
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2014-07-25
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	41163-945	41163-945-06	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Aspirin
Brand name suffix: Low Dose
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
07edcb31-d31d-4607-98c3-dcb1e062cc70	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
41163-945-06	AspirinLow Dose	1 in 1 CARTON	TABLET, DELAYED RELEASE	1	16
41163-945-06	AspirinLow Dose	200 in 1 BOTTLE	TABLET, DELAYED RELEASE	200	16
41163-945-32	AspirinLow Dose	1 in 1 CARTON	TABLET, DELAYED RELEASE	1	16
41163-945-32	AspirinLow Dose	120 in 1 BOTTLE, PLASTIC	TABLET, DELAYED RELEASE	120	16

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
41163-945-32	EA - Each	41163-945	e884ef1f-0062-4af9-bb67-341fccdabdd5	1	2018-05-09

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ASPIRIN	ACTIVE INGREDIENT	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
ASPIRIN	ACTIVE MOIETY	R16CO5Y76E	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
METHACRYLIC ACID	INACTIVE INGREDIENT	1CS02G8656	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
SHELLAC	INACTIVE INGREDIENT	46N107B71O	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
SODIUM BICARBONATE	INACTIVE INGREDIENT	8MDF5V39QO	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
41163-945	ASPIRIN LOW DOSE (ASPIRIN) TABLET, DELAYED RELEASE [UNITED NATURAL FOODS, INC. DBA UNFI]	15	Current NDC, Legacy NDC, 4 package rows	20250502_07edcb31-d31d-4607-98c3-dcb1e062cc70.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 32 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Low Dose Aspiriun	ASPIRIN	AMERIFOODS TRADING COMPANY	3802c96a-5e2a-ba9c-e063-6394a90abb78	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227aeb1-dd2c-9ca1-e063-6294a90ad709	2025-11-20	Warnings	Exact identifier application number: M013
good sense pain relief	ACETAMINOPHEN	NuCare Pharamceuticals, Inc.	440c13d7-edf0-f611-e063-6394a90af995	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227a2cc-69fa-869d-e063-6294a90a1d41	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	422796ed-7558-f7e8-e063-6294a90ad1c7	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	3e61abe4-b4be-01af-e063-6394a90a8b24	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	HYVEE INC	3e60703b-a5cf-333a-e063-6394a90a2087	2025-11-20	Warnings	Exact identifier application number: M013
ASPIRIN	ASPIRIN	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	54e4ae54-caf8-4105-8428-256f56a2f68f	2025-11-19	Warnings	Exact identifier application number: M013
MIDOL COMPLETE	ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE	R J General Corporation	0c09a178-1a07-4079-b4a6-d1657cb8e714	2025-11-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Original	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	R J General Corporation	dbb0d067-71f0-45e4-bc98-548cf4a90b3a	2025-11-17	Warnings	Exact identifier application number: M013
MOTRIN IB	IBUPROFEN	R J General Corporation	afa87bb5-7fcb-4ccd-acac-f7931242181f	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	99e45e83-37a3-44df-9a2a-98ba7457a5bb	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL PM EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	a40ea0e3-d666-4605-b5e0-beeaf8f586f2	2025-11-17	Warnings	Exact identifier application number: M013
Acetaminophen 250 mg and Ibuprofen 125 mg	ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG	R J General Corporation	68d3be55-9340-4cc9-a05a-12b9338ddc56	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	dd9aaf80-6c2b-41a3-87b9-61642aaed4f0	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c18a2da-1718-4c00-aea8-9fb4a3418312	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	cd3060a5-3b90-42e4-89cd-3b620859045f	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c7221ae-52d1-4d18-b586-c47ff656150d	2025-11-17	Warnings	Exact identifier application number: M013
Excedrin Extra Strength Headache	ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE	R J General Corporation	907c89e7-2482-465f-9f85-2381ecab1b86	2025-11-17	Warnings	Exact identifier application number: M013
Bayer Genuine Aspirin	ASPIRIN	R J General Corporation	23daa359-d40f-4f64-81be-6d154f41df9f	2025-11-17	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	07edcb31-d31d-4607-98c3-dcb1e062cc70	16
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	07edcb31-d31d-4607-98c3-dcb1e062cc70	16
308416	ASA 81 MG Delayed Release Oral Tablet	SY	07edcb31-d31d-4607-98c3-dcb1e062cc70	16
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	07edcb31-d31d-4607-98c3-dcb1e062cc70	16

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
41163-945-06	41163094506	1 in 1 CARTON					Historical
41163-945-32	41163094532	1 BOTTLE, PLASTIC in 1 CARTON (41163-945-32) / 120 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC	2014-07-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Equaline 44-645	United Natural Foods, Inc. dba UNFI \| LNK International, Inc.	2026-04-22	HUMAN OTC DRUG LABEL	16